MENU
TOVX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Theriva Biologics (TOVX) Earnings Date & Reports

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs... Show more

A.I. Advisor
published Earnings

TOVX is expected to report earnings to fall 14.29% to -5 cents per share on March 18

Theriva Biologics TOVX Stock Earnings Reports
Q4'26
Est.
$-0.06
Q2'26
Missed
by $0.01
Q1'26
Beat
by $0.16
Q4'25
Beat
by $1.17
Q3'25
Beat
by $0.68
The last earnings report on August 11 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 270.67K shares outstanding, the current market capitalization sits at 9.02M.